0001493152-17-004195.txt : 20170419 0001493152-17-004195.hdr.sgml : 20170419 20170419204929 ACCESSION NUMBER: 0001493152-17-004195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170417 FILED AS OF DATE: 20170419 DATE AS OF CHANGE: 20170419 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VBI VACCINES INC. CENTRAL INDEX KEY: 0000704159 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930589534 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 6178303031 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: PAULSON CAPITAL (DELAWARE) CORP. DATE OF NAME CHANGE: 20140326 FORMER COMPANY: FORMER CONFORMED NAME: PAULSON CAPITAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeWilde Michel CENTRAL INDEX KEY: 0001615614 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18188 FILM NUMBER: 17771151 MAIL ADDRESS: STREET 1: C/O VBI VACCINES INC. STREET 2: 222 THIRD STREET, STE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4.xml X0306 4 2017-04-17 0 0000704159 VBI VACCINES INC. VBIV 0001615614 DeWilde Michel C/O VBI VACCINES INC. 222 THIRD STREET, STE 2241 CAMBRIDGE MA 02142 1 0 0 0 Option (Right to Buy Common Shares) 3.79 2017-04-17 4 A 0 12500 0 A 2027-01-26 Common Shares 12500 12500 D The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 26, 2017 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated April 17, 2017 (the "Option Agreement"). The options vest and become exercisable in 48 equal monthly installments beginning on the first day of the month following the Grant Date. The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement. /s/ Michel DeWilde 2017-04-19